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LP (a) levels and apo (a)
phenotypes in urban black
South African men
M E Carstens, L J Burgess, J J F Taljaard
Objective. To investigate the lipoprotein (a) (Lp (a» levels
and apolipoprotein (a) (apo (a» phenotypes in a group of
urban black South African men.
Design. Cross-sectional design.
Setting. Lead acid battery plant, East London, Eastern
Cape.
Participants. Blood samples from a study on the
association between lead and renal failure were kindly
donated for the present study and 111 of the donors
participated (K Steyn - personal communication).
Outcome measures. Lp (a) levels and apo (a)
phenotypes.
Results. Three groups were identified: those with normal
« 300 U/I), intermediate (300 - 700 UII) and high (> 700 UII)
plasma Lp (a) concentrations. Nine apo (a) phenotypes
and 26 combinations thereof could be discerned. Apart
from the single- and double-band phenotypes described
before, triple-band phenotypes were also present. As the
Lp (a) values increased, the relative frequency of the
single-band phenotype decreased, whereas the relative
frequency of the double-band phenotype increased. The
relative frequency of the triple-band phenotype was
highest in the group with high Lp (a) concentrations. No
correlation was evident between the size of the apo (a)
isoforms and the Lp (a) concentrations.
Conclusions. Raised plasma Lp (a) levels have been
associated with coronary heart disease (CHO). In addition,
it has been proposed that the apo (a) gene determined
plasma Lp (a) concentrations. These studies were
performed using plasma from white subjects. CHO is
uncommon in black South Africans. The reason may be
that, given the lack of relationship between the size of the
apo (a) isoforms and the Lp (a) concentrations observed in
the present study, factors other than the isoform size may
determine the Lp (a) levels in this particular ethnic group.
S Atr Med J 1998; 88: 139-142.
lipoprotein (a) (Lp (a» is a plasma protein similar in size and
lipid composition to low-density lipoprotein (LOL).' In
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addition to apo B100, the molecule contains another
glycoprotein, apolipoprptein (apo (a», which bears a strong
resemblance to plasminogen! Lp (a) exhibits both inter-
individual and intra-individual heterogeneity, in terms of size
(280 - 800 kD) and hydrated density!·3 This heterogeneity is
mostly accounted for by the striking size polymorphism of
apo (a)!·3
Extended family studies demonstrated that the Lp (a) trait
was inherited' and that Lp (a) represented a quantitative
rather than a qualitative genetic trait.'
Gel electrophoresis and immunoblotting have identified
between 6 and 34 apo (a) isoforms, depending on the
method used."·
The factors controlling Lp (a) plasma levels have not been
clearly defined. An inverse relationship between the apo (a)
size and plasma Lp (a) levels has been documented;·
however, alleles of the same size may be associated with an
up to 200-fold difference in Lp (a) concentrations.' In
addition, ethnic differences in Lp (a) levels also occur for the
same apo (a) size. '°·"
Lp (a) plays a role in the atherosclerotic process. 12 The
lipoprotein accumulates in atherosclerotic plaques,"
stimulates smooth-muscle proliferation14 and promotes
cholesterol accumulation in cells,15 It may also promote
thrombosis because of its structural similarities to
plasminogen.'·
Black South Africans have been reported to have a
protective lipid and lipoprotein profile associated with their
low prevalence of coronary heart disease (CHD).17 The
present study was therefore undertaken to investigate the
Lp (a) values and apo (a) phenotypes in a group of black
urban South African men.
Methods
Subjects
Plasma samples from black South African men working at a
lead acid battery plant in the Eastern Cape were employed.
Lp (a) values were determined immediately, after which the
samples were stored at -20°C for approximately 1 year prior
to the'commencement of the investigation into the apo (a)
phenotypes. It should be emphasised that storage of
samples for up to 24 months at either -20°C or -aO°C has
no effect on the detection of apo (a).1. Of the samples
received, 111 were used.
Lp (a)
Lp (a) values were determined with a Pharmacia Apo (a)
solid phase two-site immunoradiometric assay. The method
is based on the direct sandwich technique in which two
monoclonal antibodies are directed against separate
antigenic determinants on the apo (a) molecule. During
incubation apo (a) in the sample reacts with 12SI-anti-apo (a)
antibodies and anti-apo (a) antibodies bound to sepharose
particles. The antibody-antigen complex formed is
separated from excess tracer by addition of decanting
suspension, followed by centrifugation and decanting. The
radioactivity in the pellet is proportional to the concentration
of apo (a) in the sample. Normal values for this laboratory
are < 300 UII.
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Electrophoresis
Samples were diluted according to their Lp (a) values in
0.15M phosphate buffer pH 6.8, containing 12.5% glycerol,
2% sodium dodecyl sUlphate (SOS), 5% ~-mercapto­
ethanol and 0.001 % bromophenol blue. After boiling for 5
minutes in a boiling bath, aliquots ranging from 10 ~I to 25 ~I
were electrophoresed.
An Lp (a) standard (Pharmacia Apo (a) RIA) was included
occasionally to monitor the immunoblotting procedure, while
apo 8100 (prepared from plasma saturated with sodium
chloride and spun on a saline gradient in an ultracentrifuge)
was included in each run as a reference for the position of
the different phenotypes on the gel.'·
The gels used in the present study were gradient SOS-
polyacrylamide gels (SOS-PAGE), 3 - 20%,20 for the
separation of large proteoglycans. An LK8"2001 (8romma,
Sweden) vertical gel electrophoresis unit was used.
Electrophoresis was performed overnight at a constant
current of 17 mA, after which the gels were removed for
electroblotting.
Electroblotting
Transfer of proteins from the gradient gels to nitrocellulose
(Hybond-C, 0.45 ~, Amersham, UK) was performed
according to a modification of the semi-dry method
described by Lauriere!' The system used was a Polyblot
Transfer System, Model S80-1000 (American 8ionetics).
The buffer system included two anode buffers, 0.3M Tris,
20% methanol pH 10.4 and 25 mM Tris, 20% methanol pH
10.4, respectively, and a cathode buffer, 25 mM Tris, 40 mM
6-aminohexanoic acid, 20% methanol pH 9.4.
810tting was carried out at 2.5 mNcm2 of gel area for 20
minutes. Subsequently the nitrocellulose was cut, one
section containing the samples and the other the apo 8100.
The latter section was stained with amido black 108 (Sigma
Chemical Company, St Louis, Mo.), 0.5% in 50% methanol,
10% acetic acid, and destained in 45% methanol, 10%
acetic acid.
Immunoblotting
The method used for immunoblotting of the apo (a)
phenotypes was essentially that of Huang et aI. 22 After the
electroblotting, the nitrocellulose section bearing the
electrophoresed samples was transferred to a solution of
3% bovine serum albumin (8SA) in Tris-buffered saline (T8S)
to saturate free protein-binding sites. After 5 hours the
nitrocellulose was incubated with human anti-Lp (a) (1 ~g/ml;
80ehringer Mannheim, Germany) in T8S containing 1% 8SA
and 0.05% Tween 20 (dilution buffer) overnight; after
extensive washing with T8S, the blot was incubated with
anti-mouse IgG 8iotin conjugate in dilution buffer
(500 ng/ml; Sigma Chemical Company, St Louis, Mo.) for 2
hours. Once again the blot was washed with T8S and then
transferred to streptavidin-peroxidase in dilution buffer
(500 ng/ml; Sigma Chemical Company, St Louis, Mo.) for 1
hour. Finally, after washing with T8S, the substrate,
diaminobenzidine (0.05%; Sigma Chemical Company, St
Louis, Mo.) in T8S with CoCI2(0.002%), NH.NiSO. (0.002%)
and HP2 (50 ~I of a 30% solution) was added to the blot for
20 minutes, after which the latter was rinsed with Hp and
the positions of the Lp (a) phenotypes noted and compared
with that of apo 8100.
Statistics
Comparison of Lp (a) concentrations was performed by
means of the Mann-Whitney U-test. Comparison of apo (a)
frequencies between groups with high (> 700 UII),
intermediate (300 - 700 UII) and normal « 300 UII) Lp (a)
values was done with the X2-test.
Results
The Lp (a) values of the sample population varied
tremendously and it was therefore decided to distinguish
three groups and to investigate the apo (a) phenotypes in
each group. The groups included Lp (a) values < 300 UII
(N =36), 300 - 700 UII (N =40) and> 700 UII (N =35). The
difference between the former two groups, as well as the
latter two, was highly significant (P =0.0, Mann-Whitney U-
test). Total cholesterol and LOL cholesterol values for the
different groups were as follows: 4.8 ± 1.00 and 2.6 ± 1.00,
respectively « 300 UII, mean ± SO), 4.8 ± 0.94 and 2.8 ±
0.88, respectively (300 - 700 UII, mean ± SO) and 4.9 ± 0.88
and 2.9 ± 0.93, respectively (> 700 UII, mean ± SO).
As far as the apo (a) phenotypes are concerned, Fig. 1 is
a representation of an immunoblot. Lane a shows a position
of apo 8100, lane b phenotypes F1, 8 and S3 (Lp (a): 984
UII), lane c phenotypes S2 and S3 (Lp (a): 1 546 UII), lane d
phenotypes S1, S2 and S3 (Lp (a): 654 UII), lane e
phenotype S1 (Lp (a): 591 UII), lane f phenotype S1 (Lp (a):
239 UII) and lane g phenotypes S1 and S3 (Lp (a): 123 UII).
Fig. 1. A representative photograph of an immunoblot. (Lane a: apo 8100; b: phenotypes F1, Band 53; Lp (a) 984 uti; c: phenotypes 52
and 53; Lp (a) 1 564 U/I; d: phenotypes 51, 52 and 53; Lp (a) 654 U/I; e: phenotype 51; Lp (a) 591 U/I; f: phenotype 51; Lp (a) 239 U/I' g:
phenotypes 51 and 53; Lp (a) 123 U/I.) ,
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Table 11. Relative frequencies of groups of apo (a) phenotypes
observed in urban black South African men
of the double-band phenotype increased. The relative
frequency of the triple-band phenotype was highest among
those men with the high Lp (a) values, while the relative
frequency of the null phenotype was highest among the low
Lp (a) samples.
< 300 300 - 700 > 700
Relative frequencies (%)
Lp (a) (U/I)
33
53
10
3
44
50
3
6
57
29
4
11
8ingle-band
Double-band
Triple-band
Null
Apo (a) phenotype groups
Table I. Apo (a) phenotypes and their respective frequencies
observed in urban black South African men
An interesting observation was the large number of
phenotypes, Le. 9, and the even larger number of
combinations, Le. 26, present in the test sample (Table I).
Unfortunately, because of this, as well as the fact that the
frequencies were low, the x2-test was unable to establish
significant differences between groups. However, an
interesting observation was the presence of triple-band
phenotypes, apart from the single- and double-band
phenotypes described before (Table 1).'9 These samples were
repeated; however, the results remained the same. In each
group, one or more null phenotypes were present, despite
the fact that Lp (a) levels were high in some of the samples.
Repeating the electrophoresis and blotting steps once again
yielded similar results.
Table 11 shows the different phenotype groups and the
relative frequencies in each of the three sample groups. An
interesting observation was that as the Lp (a) values
increased, the relative frequency of the single-band
phenotype decreased and, inversely, the relative frequency
< 300 300 - 700 > 700
Observed frequencies
Lp (a) (UIl)
2
Discussion
In the present study, plasma samples, kindly donated by the
lead study, were evaluated for Lp (a) values and apo (a)
phenotypes in urban black South African men. The Lp (a)
concentrations in the samples varied and three groups were
therefore identified: those with normal « 300 UII),
intermediate (300 - 700 UIl) and high (> 700 UlI) values. Ape
(a) phenotypes in each of these groups were determined by
SOS-PAGE, e1ectro- and immunoblotting. Although the
sample size in each group was small as a result of the cost
involved, especially that of SOS-PAGE, interesting
observations were made. The large number of apo (a)
phenotypes observed (9) and the SUbsequent combinations
(26) are in agreement with results from a similar study"
These authors identified 34 different apo (a) isoforms in a
sample of black Americans with a high-resolution SOS-
agarose gel electrophoretic method. Another group'O also
reported the presence of 101 distinct phenotypes in a group
of American blacks, using SOS-agarose gel electrophoresis.
Other studies have reported smaller phenotype numbers;,,'9
however, the method of separation of very-high-molecular-
weight proteins plays a role in the outcome of the results.
The gradient gels used in the present study>" have
particularly been suggested for the apo (a) proteins of which
the molecular weights range between 200 and 800 kO.>
Another interesting observation was the decrease in the
relative frequency of single-band phenotypes with increasing
concentrations of Lp (a), while the relative frequency of the
double-band phenotype showed an increase with increasing
Lp (a) concentrations. As far as each single-band phenotype
was concerned, however, only the S1 tended to be more
frequent among the mid-range of Lp (a) concentrations. In
addition, this is the first study to report the possible
existence of a triple-band phenotype. At least one was
observed in each of the groups studied. Since Lp (a) is a
single allele, it would be expected that either one or two
isoforms would be present in a patient. The third band
observed in the present study could be a true novel
Although it has previously been suggested that the size of
the apo (a) isoforms correlated negatively with the plasma
Lp (a) concentrations,23 this was not evident in the present
study.2
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observation, or may be due to a combination of two
isoforms. With regard to the null phenotype, we are not able
to explain its existence, despite the fact that in each case
Lp (a) was present.
Although high levels of Lp (a) have been found to be
associated with increased cardiovascular risk! this does not
seem to be the case in this particular ethnic group. Results
from the lead study clearly showed that total cholesterol
levels in urban black South Africans fell within the normal
range and were lower than in other groups including whites,
coloureds and Asians. 17 In addition, the LDL-cholesterol
levels of the black men from the lead study also fell within
the normal range. Heterozygotes for familial
hypercholesterolaemia have been shown to have about a
threefold increase in plasma Lp (a) concentrations.' It has
subsequently been proposed that for Lp (a) to exert its
adverse effects, a concomitantly raised LDL-cholesterollevel
was important.'2
A possibility may be that Lp (a), because of its structural
similarities to plasminogen
'
• and its having been shown to
inhibit activation of the latter!' prevents clot dissolution in
the blood vessel wall. LDL is known to enter macrophages
in an oxidised form; these in turn enter vessel endothelial
cells, forming foam cells!' These foam cells cause damage
to the vessel wall with subsequent clot formation.25 Because
of the damage caused to the vessel wall, Lp (a) is able to
enter'· and in that way prevent clot dissolution. Since their
total and LDL-cholesterollevels are normal,17 this may
protect black South Africans from the risk of CHD, even in
the presence of such high Lp (a) levels.
Another possible reason for CHD's being rather
uncommon in black South Africans may be that their Lp (a)
genetics differ from those of other ethnic groups, including
whites and Asians, known to have a high risk of CHD. 17 It
has been suggested that in some non-Caucasian ethnic
groups Lp (a) levels may be determined by factors that are
different from the apo (a) size polymorphism.' However, it
should be mentioned that although the blacks in the present
study seem to be protected against CHD, it has been shown
in another study" that all the elements of a potential
epidemic of atherosclerotic cardiovascular disease were
present in black populations, urban and rural, indicating the
advanced stage of westernisation. Future studies should be
able to cast light on the possible involvement of Lp (a) in
CHD in this ethnic group.
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